Securities Litigation

We represent clients in a broad range of securities and investment disputes, both within the U.S. and on cross-border matters related to overseas investment issues. These matters included allegations of fraudulent misrepresentation, fraud, breaches of fiduciary duty, and regulatory violations. We have represented individual investors, shareholders, and financial institutions in securities litigation claims.

Representative Matters

Winfield v. Eloxx Pharmaceuticals, Inc., 19-cv-447-RGA (D. Del.) (Obtained a favorable settlement of plaintiff’s securities claim after defeating motion to dismiss) 

Nash v. Qualtrics International, Inc., 2024 WL 2505911 (D. Del. May 24, 2024) (substantially defeated motion to dismiss plaintiff’s claim of securities fraud).

Represented numerous individual and institutional investors in disputes against funds and fund managers; obtained judgments and settlements making investors whole.

Represented biotech-focused private equity fund in 13D and proxy fight litigation in Delaware Chancery Court and U.S. District Court; obtained TRO to stop challenged transaction.

Represented the investment advisor arm of a national bank in connection with an SEC investigation concerning alleged disclosure violations, resulting in no action taken by the SEC.

Represented offshore fund directors in connection with SEC and DOJ investigations.

Represented private company in DOJ, DOL, and ICE employment investigations and settlement.